A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling during their standard of care treatment.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Zgoda na uczestnictwo w badaniu
- •Potwierdzona biopsją zaawansowana lub nawracająca choroba nieniska do operacji
- •Planowane leczenie pierwszej linii immunoterapią
- •Możliwość pobrania próbki guza
✗ Disqualifies
- •Inne niż płaskonabłonkowy typ raka głowy i szyi
- •Nawrót choroby w ciągu 6 miesięcy po pierwszym leczeniu chemioterapią
- •Guz bez określonych markerów immunologicznych
- •Inny aktywny nowotwór w ostatnich 2 latach
- •Brak możliwości regularnego pobierania krwi do badań
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 3, 2026
- Sex
- No restrictions
Locations (32)
City of Hope
Duarte, United States
USC/Norris Comprehensive Cancer Center
Los Angeles, United States
University of California, Los Angeles
Los Angeles, United States
Stanford
Palo Alto, United States
Providence Medical Foundation
Santa Rosa, United States
Mayo Clinic Florida
Jacksonville, United States
Morehouse
Atlanta, United States
Piedmont Healthcare
Atlanta, United States
Winship Cancer Institute, Emory University
Atlanta, United States
Northwestern University Feinberg School of Medicine
Chicago, United States
Cancer Care Specialists of Illinois
Decatur, United States
Illinois Cancer Care
Peoria, United States
University of Kansas
Westwood, United States
University of Maryland
Baltimore, United States
Dana Farber Cancer Institute
Boston, United States
Henry Ford
Detriot, United States
Karmanos Cancer Institute
Detroit, United States
Mayo Clinic Rochester
Rochester, United States
Oncology Hematology Associates
Springfield, United States
Washington University in St. Louis
St Louis, United States
Mount Sinai Hospital
New York, United States
Sanford Fargo
Fargo, United States
University of Cincinnati
Cincinnati, United States
Cleveland Clinic
Cleveland, United States
Ohio State University
Columbus, United States
University of Pennsylvania
Philadelphia, United States
Cancer Care Associates of York
York, United States
Sanford Sioux Falls
Sioux Falls, United States
Vanderbilt University
Nashville, United States
University of Washington
Seattle, United States
ThedaCare
Appleton, United States
Pan American Cancer for Oncology
San Juan, Puerto Rico
Trial contact
Phoenix HNSCC
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/4/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.